Lyn Jones

bio wrapper

headshot column

bio sketch column

Lyn Jones completed PhD studies in synthetic organic chemistry at the University of Nottingham, before starting his post-doctorate research at The Scripps Research Institute, California in the area of chemical biology. In 2001, he joined Pfizer in Sandwich, UK as a medicinal chemistry team leader, and in 2009, he won the inaugural Royal Society of Chemistry Young Industrialist of the Year Award for his contributions to HIV and COPD research and clinical candidate delivery. In 2011, he transferred to Cambridge, MA to become head of Rare Disease Chemistry and to lead the Chemical Biology Group. In 2017, he joined Jnana Therapeutics in Boston (VP, Chemical Biology). He is an author or inventor on over 100 publications and patents, a fellow of the Royal Society of Chemistry (FRSC) and the Royal Society of Biology (FRSB), and he is an elected member of the Chemistry Biology Interface Division Council of the RSC.